Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP-1R agonists to treat some central nervous disorders is promising, but comparatively understudied.
Login or Register for a free MyNAP member account to save 10% off online and receive other benefits. [Learn More] Since artificial intelligence's (AI) inception, AI and neuroscience have influenced each other to advance models of neural circuitry, analyze large and complex datasets, and inform the development of AI algorithms.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
